Share Name Share Symbol Market Type Share ISIN Share Description
Physiomics Plc LSE:PYC London Ordinary Share GB00B04QT956 ORD 0.004P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 0.024p 0.023p 0.025p 0.0245p 0.024p 0.024p 32,150,811 13:12:37
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 0.2 -0.4 -0.0 - 1.37

Physiomics (PYC) Latest News

More Physiomics News
Physiomics Takeover Rumours

Physiomics (PYC) Share Charts

1 Year Physiomics Chart

1 Year Physiomics Chart

1 Month Physiomics Chart

1 Month Physiomics Chart

Intraday Physiomics Chart

Intraday Physiomics Chart

Physiomics (PYC) Discussions and Chat

Physiomics Forums and Chat

Date Time Title Posts
20/10/201610:25Physiomics with Charts & News13,598
19/10/201623:28PHYSIOMICS plc Virtual Tumor platform2,750
30/4/201416:39One for Haystack to deramp !1
04/12/201319:04PHYSIOMICS WHAT A JOKE 00.15p GET OUT13

Add a New Thread

Physiomics (PYC) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
View all Physiomics trades in real-time

Physiomics (PYC) Top Chat Posts

Physiomics Daily Update: Physiomics Plc is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker PYC. The last closing price for Physiomics was 0.02p.
Physiomics Plc has a 4 week average price of 0.03p and a 12 week average price of 0.03p.
The 1 year high share price is 0.07p while the 1 year low share price is currently 0.02p.
There are currently 5,701,657,918 shares in issue and the average daily traded volume is 250,552,863 shares. The market capitalisation of Physiomics Plc is £1,368,397.90.
the stigologist: Not a good sign when share price goes below recent placing price. Shows Company and Brokers not in control, they must have placed to some real low quality bucket shops which will cause big overhang going forward.
aberystwyth: Pity PYC could not be taken over for a 100% increase in current share price .... I see no other way of getting my money back on this dog of a share
bobdown2: If the new ceo delivers the long awaited contracts then the share price will be many multiples of the existing share price..the fees for work done will become what they were meant to be..stepping stones to contracts and hopefully the big boys will not be able to exploit an aim minnow anymore. A contract was once said to be worth 250 k and so if a few were signed the potential for a major share price rise would be definitely on the cards...a good long term hold with the promise of an initial rise..
bobdown2: My apologies....that r.n.s came in under the looks like p.y.c have finally got a c.e.o capable of getting the contracts signed hence the share price rise...where the price goes now depends on his competence and contacts..
naplion: so what now? everything look good in words , but how is that going to effect the share price a company is trying to raise money 4 times folds the current value , i am sure they have a plan for that before they went into talks and it cant be another YAA deal for sure as this will dilute the share massivley for such an amount and for a really long time that it will not allow them to raise more money after that when needed . in my opnion, they must have some good deals lined up and they hinted that the result of thier latest deal will be more then impressive ... all in all , looks good going forward but lets see what the market thinks . its also good to see losses are narrowing ...
pwhite73: Nobody is doubting the technology but no one knows why the share price is still in the gutter. Only last week the US FDA refused to grant AstraZeneca approval for their lead diabetes compounds. Advising more clinical trials were still required. Perhaps this is the time for PYC but deceitful market operators are still at work here and forever will be. Always at the expense of retail shareholders. Is this new positive tide for real and can it drown them all. That is the question?.
bobdown2: hi.. i also did not like the lack of news!especialy after results that stated pyc had never received so much interest. i bought loads in the second fund raise as this is normally the bottom and a good buying point...fully funded etc.. in dismay i watched as the second fund raise was as bad as the first. it looked like another swap!!!!!!!i had intended to take my holding to the 3% mark and get a picture of the rns put up in my or what. but..without any new revenue, i could envisage another good rns followed by yet another fund raise! one of the reasons the share price has been weak over the the last few weeks has been me selling my 2.3%. i now have 1 million left. i noticed someone bought 8 million shares today and i wish him/her all the best. i hope he knows more about the company than i do. the lack of progress and revenue was a risk i was not prepared to take...bob
pwhite73: There may well be contract news to be announced very shortly. The problem with this company is that it attaches diluted equity issues to any contracts or support in the share price as a right of passage. Good news + buying in the stock = diluted placings. Until that equation is cancelled the share price will go nowhere. The company as a matter of principle does not allow retail shareholders to profit from any strength in the share price. History has shown this and it will repeat itself time and time again. If the company receives a takeover approach then that is the only time the cycle can be broken.
bobdown2: as i would like pyc as a long term investment obviously i would like to see another clinical contract! an immunology contract would be the icing on the cake. toxicology take up would be the candles! a share price rise on the back of rising revenues is the goldilocks scenario! costs are rising as the company expands and revenue would take out any funding issues and hopefully show that pyc is headed for profitability. as stated in a recenr rns! yep.. contract news would drive pyc.s share price to sustainable higher levels. now the swap shares are gone lets enjoy what should be a pleasant rising share price. i am looking forward to next week..
redtelephonegreen2: The potential upside of PYC share price is unbelievably huge.Should their technology be worthy this could be a 30,40,50 bagger.To have 3 major pharma companies taking up their digital models in the last few months indicates that there is a lot of promise here.Of course its a high risk share but thats when returns are potentially the highest.By the time their technology is proven to be of imense values to the pharma/bio industies thean those not already on board would have missed the opportunity and the share price would be at 30+ times the value today.i think its a great time to buy when we already know that newsflow is not far away and there seems to be low interest.Im in for long term. Of course you have the risk of losing all but worth a shot if you are a calculated speculator.But I personally think they have a slow cashburn and are a regular benifactor from charity.
Physiomics share price data is direct from the London Stock Exchange
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20161021 14:48:30